SGLT2 inhibitors: providing cardiovascular protection in type 2 diabetes?

被引：0
|
作者：
Wilding, John [1 ]
机构：
[1] Aintree Univ Hosp NHS Fdn Trust, Obes & Endocrinol Res, Inst Ageing & Chron Dis, Ctr Clin Sci, Liverpool L9 7AL, Merseyside, England
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2016年 / 4卷 / 05期
关键词：
OUTCOMES;
D O I：
10.1016/S2213-8587(16)00084-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：379 / 381
页数：4
相关论文
共 50 条
  • [1] SGLT2 Inhibitors for Type 2 Diabetes
    Liu, Jiwen
    Lee, TaeWeon
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 46, 2011, 46 : 103 - +
  • [2] SGLT2 Inhibitors: Benefits for CKD and Cardiovascular Disease in Type 2 Diabetes
    Singhal, Rohit
    Hechanova, Lisa Aimee
    [J]. CURRENT CARDIOLOGY REPORTS, 2022, 24 (03) : 183 - 189
  • [3] SGLT2 Inhibitors: Benefits for CKD and Cardiovascular Disease in Type 2 Diabetes
    Rohit Singhal
    Lisa Aimee Hechanova
    [J]. Current Cardiology Reports, 2022, 24 : 183 - 189
  • [4] SGLT2 inhibitors: hypotheses on the mechanism of cardiovascular protection
    Bell, Robert M.
    Yellon, Derek M.
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (06): : 435 - 437
  • [5] SGLT2 inhibitors in the treatment of type 2 diabetes
    Hasan, Farhad M.
    Alsahli, Mazen
    Gerich, John E.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 104 (03) : 297 - 322
  • [6] SGLT2 inhibitors in the management of type 2 diabetes
    Reddy, R. P. Monica
    Inzucchi, Silvio E.
    [J]. ENDOCRINE, 2016, 53 (02) : 364 - 372
  • [7] SGLT2 inhibitors in the management of type 2 diabetes
    R. P. Monica Reddy
    Silvio E. Inzucchi
    [J]. Endocrine, 2016, 53 : 364 - 372
  • [8] SGLT2 Inhibitors in Type 2 Diabetes Mellitus
    Ferrannini, Giulia
    Savarese, Gianluigi
    Cosentino, Francesco
    [J]. HEART FAILURE CLINICS, 2022, 18 (04) : 551 - 559
  • [9] SGLT2 Inhibitors - The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review
    Seidu, Samuel
    Alabraba, Vicki
    Davies, Sarah
    Newland-Jones, Philip
    Fernando, Kevin
    Bain, Stephen C.
    Diggle, Jane
    Evans, Marc
    James, June
    Kanumilli, Naresh
    Milne, Nicola
    Viljoen, Adie
    Wheeler, David C.
    Wilding, John P. H.
    [J]. DIABETES THERAPY, 2024, 15 (05) : 1099 - 1124
  • [10] Type 2 Diabetes, SGLT2 Inhibitors, and Glucose Secretion
    Hattersley, Andrew T.
    Thorens, Bernard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (10): : 974 - 976
12345